PRISCILLA LAWRENCE: Open Payments
NPI 1699724641 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$542 in 18 payments from 12 companies in 2025. Trend: 2023 $113 · 2024 $103 · 2025 $542
Food & beverage: $343Long term medical supply or device loan: $199
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $205 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Caris MPI, Inc. | 1 | $58 |
| Janssen Biotech, Inc. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 1 | $36 |
| Incyte Corporation | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| GENZYME CORPORATION | 1 | $19 |
| Kestra Medical Technology Services, Inc. | 1 | $19 |
Products named: KISQALI, ENHERTU, MI CANCER SEEK, OPDIVO, JAKAFI, RYBREVANT, ERLEADA, SARCLISA.
Industry payments across FL — which companies pay providers there.
